Lifevantage EBITDA Margin 2010-2025 | LFVN

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Lifevantage (LFVN) over the last 10 years. The current EBITDA margin for Lifevantage as of March 31, 2025 is .
Lifevantage EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $0.22B $0.02B 7.21%
2024-12-31 $0.21B $0.01B 6.60%
2024-09-30 $0.20B $0.01B 5.10%
2024-06-30 $0.20B $0.01B 4.50%
2024-03-31 $0.21B $0.01B 4.39%
2023-12-31 $0.21B $0.01B 3.79%
2023-09-30 $0.21B $0.01B 3.76%
2023-06-30 $0.21B $0.01B 3.74%
2023-03-31 $0.21B $0.01B 2.37%
2022-12-31 $0.21B $0.01B 2.90%
2022-09-30 $0.21B $0.01B 3.41%
2022-06-30 $0.21B $0.01B 5.34%
2022-03-31 $0.21B $0.02B 8.57%
2021-12-31 $0.21B $0.02B 8.49%
2021-09-30 $0.22B $0.02B 10.96%
2021-06-30 $0.22B $0.02B 10.86%
2021-03-31 $0.23B $0.02B 10.67%
2020-12-31 $0.23B $0.03B 10.92%
2020-09-30 $0.23B $0.02B 9.96%
2020-06-30 $0.23B $0.02B 9.05%
2020-03-31 $0.23B $0.02B 8.30%
2019-12-31 $0.23B $0.02B 7.86%
2019-09-30 $0.23B $0.01B 6.19%
2019-06-30 $0.23B $0.01B 5.31%
2019-03-31 $0.22B $0.01B 4.91%
2018-12-31 $0.22B $0.01B 5.02%
2018-09-30 $0.21B $0.01B 6.19%
2018-06-30 $0.20B $0.01B 6.40%
2018-03-31 $0.20B $0.01B 5.00%
2017-12-31 $0.19B $0.01B 4.12%
2017-09-30 $0.19B $0.01B 3.09%
2017-06-30 $0.20B $0.01B 3.00%
2017-03-31 $0.20B $0.01B 4.46%
2016-12-31 $0.21B $0.01B 5.63%
2016-09-30 $0.22B $0.02B 6.94%
2016-06-30 $0.21B $0.02B 7.77%
2016-03-31 $0.20B $0.01B 6.57%
2015-12-31 $0.19B $0.01B 5.88%
2015-09-30 $0.18B $0.01B 6.01%
2015-06-30 $0.19B $0.02B 8.42%
2015-03-31 $0.20B $0.02B 9.45%
2014-12-31 $0.21B $0.02B 10.43%
2014-09-30 $0.22B $0.02B 11.16%
2014-06-30 $0.21B $0.02B 10.28%
2014-03-31 $0.21B $0.02B 8.57%
2013-12-31 $0.21B $0.02B 8.29%
2013-09-30 $0.21B $0.01B 5.83%
2013-06-30 $0.21B $0.01B 6.25%
2013-03-31 $0.20B $0.02B 9.95%
2012-12-31 $0.19B $0.02B 12.30%
2012-09-30 $0.16B $0.03B 16.35%
2012-06-30 $0.13B $0.02B 18.25%
2012-03-31 $0.10B $0.02B 17.71%
2011-12-31 $0.07B $0.01B 12.86%
2011-09-30 $0.05B $0.01B 13.46%
2011-06-30 $0.04B $0.00B 7.89%
2011-03-31 $0.03B 0 0.00%
2010-12-31 $0.02B 0 0.00%
2010-09-30 $0.02B $0.00B -26.67%
2010-06-30 $0.01B $-0.01B -63.64%
2010-03-31 $0.01B $-0.01B -122.22%
2009-12-31 $0.01B $-0.01B -171.43%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.160B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.096B 21.51
Becton Dickinson (BDX) United States $49.586B 12.28
Cardinal Health (CAH) United States $36.549B 19.14
Labcorp (LH) United States $20.676B 16.77
Straumann Holding AG (SAUHY) Switzerland $20.594B 0.00
Cooper (COO) United States $16.022B 21.25
West Pharmaceutical Services (WST) United States $15.187B 31.84
Align Technology (ALGN) United States $13.055B 25.92
Henry Schein (HSIC) United States $8.934B 15.32
Merit Medical Systems (MMSI) United States $5.581B 26.98
DENTSPLY SIRONA (XRAY) United States $3.290B 9.83
CONMED (CNMD) United States $1.766B 13.21
STAAR Surgical (STAA) United States $0.895B 0.00
Pro-Dex (PDEX) United States $0.135B 14.75